CY1291A - Androstane 17 beta carbothioates - Google Patents
Androstane 17 beta carbothioatesInfo
- Publication number
- CY1291A CY1291A CY129181A CY129181A CY1291A CY 1291 A CY1291 A CY 1291A CY 129181 A CY129181 A CY 129181A CY 129181 A CY129181 A CY 129181A CY 1291 A CY1291 A CY 1291A
- Authority
- CY
- Cyprus
- Prior art keywords
- carbothioates
- androstane
- beta
- beta carbothioates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8005174 | 1980-02-15 | ||
| GB8104496A GB2088877B (en) | 1980-02-15 | 1981-02-13 | Androstane 17 carbothioates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1291A true CY1291A (en) | 1985-10-18 |
Family
ID=26274506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY129181A CY1291A (en) | 1980-02-15 | 1981-02-13 | Androstane 17 beta carbothioates |
Country Status (2)
| Country | Link |
|---|---|
| CY (1) | CY1291A (en) |
| GB (1) | GB2088877B (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8630913D0 (en) * | 1986-12-24 | 1987-02-04 | Glaxo Group Ltd | Pharmaceutical compositions |
| US5270305A (en) | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
| SK280967B6 (en) | 1990-03-02 | 2000-10-09 | Glaxo Group Limited | Inhalation device |
| US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
| CA2125666C (en) | 1991-12-12 | 2002-07-16 | Rachel Ann Akehurst | Medicaments |
| IL104068A (en) † | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant |
| US5916540A (en) | 1994-10-24 | 1999-06-29 | Glaxo Group Limited | Aerosol formulations containing P134A and/or P227 and particulate medicament |
| GB9622173D0 (en) | 1996-10-24 | 1996-12-18 | Glaxo Group Ltd | Particulate Products |
| US20020133032A1 (en) | 2000-02-25 | 2002-09-19 | Jufang Barkalow | Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
| GB0009591D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medical combinations |
| GB0009606D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic combinations |
| GB0017988D0 (en) * | 2000-07-21 | 2000-09-13 | Glaxo Group Ltd | Novel process |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| AR032361A1 (en) | 2000-08-05 | 2003-11-05 | Glaxo Group Ltd | DERIVATIVES OF ANDROSTAN AND SALTS AND SOLVATOS OF THE SAME, ITS USE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH COMPOUNDS, PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS, AND USEFUL INTERMEDIARIES IN THE PREPARATION OF SUCH COMPOUNDS |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| WO2002088167A1 (en) | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| EP2266590A3 (en) | 2002-02-22 | 2011-04-20 | Shire LLC | Active agent delivery sytems and methods for protecting and administering active agents |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| US7208613B2 (en) | 2002-06-20 | 2007-04-24 | Sun Pharmaceutical Industries Limited | Synthesis of s-fluoromethyl 6α,9α-difluoro-11β-hydroxy-16α-methyl-17α-propionyloxy-3-oxoandrosta-1,4-diene-17β-carbothioate |
| EP1611149A1 (en) * | 2003-04-04 | 2006-01-04 | Alpharma APS | Process for the preparation of steroidal carbothioic acid derivatives and intermediates |
| JP4607112B2 (en) | 2003-08-11 | 2011-01-05 | グラクソ グループ リミテッド | Pharmaceutical metered dose inhaler and method associated with said aspirator |
| PT103202B (en) | 2004-10-19 | 2011-01-27 | Hovione Farmaciencia S A | PROCESS FOR THE ESTERIFICATION OF A CARBOOTHYTIC ACID |
| WO2006064283A1 (en) | 2004-12-17 | 2006-06-22 | Cipla Limited | Pharmaceutical compounds and compositions |
| AU2007258949B2 (en) * | 2006-06-14 | 2013-02-21 | Generics [Uk] Limited | Process for the preparation of S-fluoromethyl-6, 9 -difluoro-11 -hydroxy-16 -methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates |
| AU2013202843B2 (en) * | 2006-06-14 | 2015-11-12 | Generics [Uk] Limited | Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1, 4-diene-17-carbothioate and intermediates |
| CN102558273B (en) | 2010-12-14 | 2014-07-02 | 浙江省天台县奥锐特药业有限公司 | Method for preparing fluticasone furoate |
| KR102163368B1 (en) | 2011-07-08 | 2020-10-08 | 화이자 리미티드 | Process for the preparation of fluticasone propionate form 1 |
| US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| MX361886B (en) | 2012-05-08 | 2018-12-18 | Nicox Ophthalmics Inc | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof. |
| US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| EP3047846A1 (en) | 2015-01-22 | 2016-07-27 | Ems S.A. | Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagus |
| US9980975B2 (en) | 2015-01-22 | 2018-05-29 | Ems S.A. | Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagus |
-
1981
- 1981-02-13 CY CY129181A patent/CY1291A/en unknown
- 1981-02-13 GB GB8104496A patent/GB2088877B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB2088877A (en) | 1982-06-16 |
| GB2088877B (en) | 1984-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1291A (en) | Androstane 17 beta carbothioates | |
| ZW18081A1 (en) | Androstane carbothioates | |
| MY8700055A (en) | 10 - alknyl steroids | |
| CS575983A2 (en) | Zpusob vyroby novych beta laktamu | |
| JPS57189898A (en) | Note | |
| CS82782A2 (en) | Zpusob odstranovani kyslicnikovych okuji z povrchu kovovych predmetu | |
| DE3277194D1 (en) | Wingsail arrangement | |
| GB2092598B (en) | Macrofilament-reinforced composites | |
| JPS56122398A (en) | 17 alphaaacyloxyy5 beta and 5 alphaacorticoids | |
| GB8328569D0 (en) | 3 5-dinitrophthalimides | |
| GB8421987D0 (en) | 17-ethynyl-6-fluoro steroids | |
| GB2103261B (en) | Stage | |
| GB2146334B (en) | Steroid 21-sulfoxides | |
| CS961584A2 (en) | Zpusob vyroby beta laktamovych antibiotik | |
| JPS5754184A (en) | Jiokisabishikuro 3 2 1 okutanruioyobiokisepanruinoseizohoho | |
| CS425482A2 (en) | Zpusob vyroby cisteho povrchoveho antigenu hepatitidy b z lidske plasmy | |
| JPS57152999A (en) | Note | |
| ZA823782B (en) | 11 alpha-amino-androstanes | |
| GB8427294D0 (en) | 1 3 2-dioxaphospholes | |
| CS544682A2 (en) | Zpusob odebirani vody ze zasobniku podzemni vody | |
| JPS57159698A (en) | Note | |
| JPS5754147A (en) | Arukirupaafuruoro 4 77jiokisaa55mechiruu88furuorofuorumirunonanoeeto noseizoho | |
| JPS5547700A (en) | 33acetoxyy9 beta*11 betaaepoxyypregnaa 1*3*55triene and corresponding 3*55diene | |
| JPS57165297A (en) | Note | |
| JPS57200786A (en) | Duct |